A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer
The most common are gastrointestinal effects such as nausea, stomach cramps, diarrhea, or heartburn
References McDonald ES, Gillis LB, Gabriel P, et al
Disclaimer: Information and statements regarding the product/services have not been evaluated by the Food and Drug Administration or any government authority and not intended to diagnose, treat, cure, or prevent any disease_ Product/Services reviews are provided by users based on their persona, experiences & opinions, and do not reflect the opinion of HealthKart_ Product/Services information provided by the seller on HealthKart is not exhaustive, please read the label on the product carefully for complete information provided by the manufacturer_ The results from the products will vary from person to person_ No individual result should be seen as typical_ Ranked: #243 in Vitamins & Supplements
What does PlexusDx tirzepatide cost, and does the price change if I increase my dose
METABOLIC RESEARCH RETATRUTIDE 30MG LYOPHILIZED Retatrutide is a triple receptor agonist (GLP-1, GIP, glucagon) investigated in laboratory metabolic-research settings
